$OVID Income Statement | Understand Stock

$OVID

$2.26 +$0.10 (4.87%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
License and other revenue
License revenue - related party
Total revenue
Revenue
License and other revenue
License revenue - related party
Total revenue

Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other (expense) income, net
Other income (expense), net
Loss before provision for income taxes
Provision for income taxes
Net loss
Net loss per share, basic (in dollars per share)
Series A Preferred Stock
Common Stock
Total net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Series A Preferred Stock
Common Stock
Total net loss per share, diluted (in dollars per share)
Net income (loss) attributable to common stockholders
Common Stock
Total net income (loss) attributable to common stockholders
Weighted-average common shares outstanding, basic (in shares)
Series A Preferred Stock
Common Stock
Total weighted-average common shares outstanding, basic (in shares)
Weighted-average common shares outstanding, diluted (in shares)
Series A Preferred Stock
Common Stock
Total weighted-average common shares outstanding, diluted (in shares)

Comments